MAESTROS ELECTRONICS & TELECOMMUNICATIONS SYSTEMS LIMITED Maestros Electronics & Telecommunications Systems Limited Stock
Equities
METSL
INE318N01011
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159.6 INR | -2.00% |
|
-5.84% | +60.32% |
| Sales 2022 | 112M 1.34M | Sales 2023 | 246M 2.95M | Capitalization | 245M 2.94M |
|---|---|---|---|---|---|
| Net income 2022 | 12M 144K | Net income 2023 | 29M 348K | EV / Sales 2022 | 0.63 x |
| Net cash position 2022 | 224M 2.69M | Net cash position 2023 | 134M 1.6M | EV / Sales 2023 | 0.45 x |
| P/E ratio 2022 |
23.6
x | P/E ratio 2023 |
8.23
x | Employees | 85 |
| Yield 2022 |
0.93% | Yield 2023 |
-
| Free-Float | 32.14% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.00% | ||
| 1 week | -5.84% | ||
| 1 month | +5.63% | ||
| 3 months | +29.29% | ||
| 6 months | +69.57% | ||
| Current year | +60.32% |
1 week
159.55
166.10
1 month
138.00181.20
Current year
91.50181.95
1 year
59.85181.95
3 years
40.10181.95
5 years
40.10181.95
10 years
6.15181.95
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 04-12-31 | |
Sanjeev Vijayan
DFI | Director of Finance/CFO | - | - |
| Chief Tech/Sci/R&D Officer | - | 12-01-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 21-12-06 | |
| Chief Executive Officer | 55 | 04-12-31 | |
| Director/Board Member | - | 19-08-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 159.6 | -2.00% | 1,269 |
| 24-05-30 | 162.8 | -1.96% | 11,194 |
| 24-05-29 | 166 | +2.00% | 22,496 |
| 24-05-28 | 162.8 | -1.99% | 4,549 |
| 24-05-27 | 166.1 | -1.98% | 4,798 |
Delayed Quote Bombay S.E., May 31, 2024 at 06:00 am EDT
More quotes
Maestros Electronics & Telecommunications Systems Limited is an India-based design, development and manufacturing company. The Company is focused on developing products and services for financial inclusion, cardiology, gynecology, critical care patient and diseases management in medicine with rich experience in latest technologies and communication. The Company operates through two segments: Electronics & Instrumentation (E&T), and Telemedicine. The Company's product includes financial inclusion, electrocardiogram (ECG) machines, patient monitors, defibrillators, pulse oximeters, fetal monitors, home care and e-health service, and critical care. Its financial inclusion solution includes microfinance, e-Governance, receipt printing, ticketing, retail and sales, and cash/loan collection.
Calendar
2024-08-01
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +60.32% | 10.53M | |
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.61B |
- Stock Market
- Equities
- METSL Stock
